CARD15 mutations are rare in Swedish pediatric Crohn disease

Maja Ideström1, Carlos Rubio, Fredrik Granath

  • 1Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. maja.idestrom@karolinska.se

Insights

This study found a lower frequency of CARD15 mutations in Swedish children with Crohn disease (CD) compared to other populations. While no strong genotype-phenotype correlations were identified, a trend suggested a link between CARD15 mutations and granuloma formation in pediatric CD patients.

Area of Science:

  • Genetics
  • Gastroenterology
  • Pediatrics

Background:

  • Crohn disease (CD) is associated with mutations in the CARD15/NOD2 gene, involved in monocyte bacterial recognition.
  • Previous studies have reported this association in adult and pediatric populations.

Purpose of the Study:

  • To investigate CARD15 mutations in Swedish children diagnosed with Crohn disease.
  • To analyze genotype-phenotype correlations in this pediatric cohort.

Main Methods:

  • Reviewed 58 Swedish children with CD (ages 2.8-16.9 years).
  • Performed histopathology, retrospective data collection, and mutational analyses for CARD15 mutations (R702W, G908R, 1007fs).
  • Genotyped first-degree relatives of patients.

Main Results:

  • CARD15 mutations were identified in 8.6% of pediatric CD patients, all heterozygotes (allele frequency 4.3%).
  • No significant genotype-phenotype associations were found for age at onset, disease location, severity, stenosis, perianal disease, or extraintestinal manifestations.
  • A trend suggested a correlation between CARD15 mutations and granuloma formation at disease onset (80% vs 43%).

Conclusions:

  • The frequency of CARD15 mutations in Swedish pediatric CD patients is lower than previously reported.
  • Genotype-phenotype correlations were largely non-significant, but a trend for granuloma formation was observed.
  • Healthy mothers carrying CARD15 mutations transmitted them to their children with CD.
Abstract

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Mutations01:39

Mutations

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...